Predicting malignant progression in clinically high-risk lesions by DNA ploidy analysis and dysplasia grading
- PMID: 30367100
- PMCID: PMC6203726
- DOI: 10.1038/s41598-018-34165-5
Predicting malignant progression in clinically high-risk lesions by DNA ploidy analysis and dysplasia grading
Abstract
The value of image cytometry DNA ploidy analysis and dysplasia grading to predict malignant transformation has been determined in oral lesions considered to be at 'high' risk on the basis of clinical information and biopsy result. 10-year follow up data for 259 sequential patients with oral lesions clinically at 'high' risk of malignant transformation were matched to cancer registry and local pathology database records of malignant outcomes, ploidy result and histological dysplasia grade. In multivariate analysis (n = 228 patients), 24 developed carcinoma and of these, 14 prior biopsy samples were aneuploid. Aneuploidy was a significant predictor (hazard ratio 7.92; 95% CI 3.45, 18.17) compared with diploidy (p < 0.001). The positive predictive value (PPV) for severe dysplasia was 50% (95% CI 31.5, 68.5) and for aneuploid lesions, 33.3% (95% CI 19.0, 47.6). Combined DNA aneuploidy and severe dysplasia increased PPV to 56.3% (95% CI 31.9, 80.6). Diploid-tetraploid and non-dysplastic status had high negative predictive values (NPV) of 94.6% (95% CI 91.4, 97.8) and 99.17% (95% CI 97.4, 100.8) respectively. DNA ploidy predicts malignant transformation well and combining it with dysplasia grading gave the highest predictive value. The predictive values reported here exceed those from other investigations to date.
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.Cancer Prev Res (Phila). 2013 Aug;6(8):822-31. doi: 10.1158/1940-6207.CAPR-13-0001. Epub 2013 Jun 12. Cancer Prev Res (Phila). 2013. PMID: 23761273
-
Meta-analysis of the predictive value of DNA aneuploidy in malignant transformation of oral potentially malignant disorders.J Oral Pathol Med. 2018 Feb;47(2):97-103. doi: 10.1111/jop.12603. Epub 2017 Jul 5. J Oral Pathol Med. 2018. PMID: 28612463 Review.
-
DNA aneuploidy with image cytometry for detecting dysplasia and carcinoma in oral potentially malignant disorders: A prospective diagnostic study.Cancer Med. 2020 Sep;9(17):6411-6420. doi: 10.1002/cam4.3293. Epub 2020 Jul 7. Cancer Med. 2020. PMID: 32638539 Free PMC article.
-
DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression.Oral Oncol. 2009 Jun;45(6):468-73. doi: 10.1016/j.oraloncology.2008.07.006. Epub 2008 Sep 19. Oral Oncol. 2009. PMID: 18805043
-
Chromosomal instability, aneuploidy and routine high-resolution DNA content analysis in oral cancer risk evaluation.Future Oncol. 2012 Oct;8(10):1257-71. doi: 10.2217/fon.12.116. Future Oncol. 2012. PMID: 23130927 Review.
Cited by
-
Correlation Between Histological Grading and Ploidy Status in Oral Leukoplakia, Oral Submucous Fibrosis, and Oral Squamous Cell Carcinoma: A Flow Cytometric Analysis.J Pharm Bioallied Sci. 2020 Aug;12(Suppl 1):S91-S98. doi: 10.4103/jpbs.JPBS_33_20. Epub 2020 Aug 28. J Pharm Bioallied Sci. 2020. PMID: 33149437 Free PMC article.
-
Predicting Progression of Low-Grade Oral Dysplasia Using Brushing-Based DNA Ploidy and Chromatin Organization Analysis.Cancer Prev Res (Phila). 2021 Dec;14(12):1111-1118. doi: 10.1158/1940-6207.CAPR-21-0134. Epub 2021 Aug 10. Cancer Prev Res (Phila). 2021. PMID: 34376461 Free PMC article.
-
A head-to-head comparison of four grading systems for oral epithelial dysplasia.Histopathology. 2025 May;86(6):933-941. doi: 10.1111/his.15400. Epub 2024 Dec 17. Histopathology. 2025. PMID: 39688116 Free PMC article.
-
CA125, CEA, CA19-9, and Heteroploid Cells in Ascites Fluid May Help Diagnose Peritoneal Carcinomatosis in Patients with Gastrointestinal and Ovarian Malignancies.Cancer Manag Res. 2020 Oct 22;12:10479-10489. doi: 10.2147/CMAR.S271596. eCollection 2020. Cancer Manag Res. 2020. PMID: 33122947 Free PMC article.
-
Valproic acid exposure alters histone deacetylase mRNA expression profile in oral cancer and premalignant cell lines.Biomed Rep. 2025 Jun 11;23(2):135. doi: 10.3892/br.2025.2013. eCollection 2025 Aug. Biomed Rep. 2025. PMID: 40589717 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical